About

Publications While At HealthPartners

Highlights

selected publications

Journal Article

HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: Phase 1/2 trial results. 

Cell Rep Med. 2026

Phase II study of biweekly carboplatin, gemcitabine, and bevacizumab as first-line treatment in patients with stage IIIB/IV NSCLC. 

American Journal of Clinical Oncology. 2014

Abstract

Variation in care improvement opportunities suggests need for tailored clinician-specific improvement interventions [abstract]. 

Journal of patient-centered research and reviews. 2019

Contact

full name

P. Kumar

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science